Treatment of eosinophilic esophagitis - advancements andperspectives

被引:0
作者
Miehlke, Stephan [1 ,2 ]
Arnim, Ulrike von [3 ]
Schlag, Christoph [4 ]
Labenz, Joachim [5 ]
Madisch, Ahmed [6 ]
机构
[1] Magen Darm Zent, Facharztzentrum Eppendorf, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[3] Univ Klinikum Magdeburg AoR, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany
[4] Tech Univ Munich, Med Dept 2, Klinikum Rechts Isar, Munich, Germany
[5] Ev Jung Stilling Krankenhaus, Med Klin, Siegen, Germany
[6] Siloah Hosp, Dept Internal Med, Hannover, Germany
关键词
eosinophilic esophagitis; topical corticosteroids; budesonide; fluticasone; proton pump inhibitor; elimination diet; biological; BUDESONIDE ORAL SUSPENSION; HISTOLOGIC REMISSION; NATURAL-HISTORY; ADULT PATIENTS; EFFICACY; GUIDELINES; MANAGEMENT; CHILDREN; PLACEBO; DIAGNOSIS;
D O I
10.1055/a-1861-7152
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
In recent years significant progress has been made in the treatment of eosinophilic esophagitis (EoE), especially in the area of topical corticosteroids. Novel EoE-specific formulations have been developed and first approvals have been obtained for induction and maintenance of remission in adult EoE patients with the orodispersible budesonide tablet in Germany and other European and non-EU countries. A novel budesonide oral suspension is currently under priority review by the FDA for first approval in the U.S. In contrast, the scientific evidence on the efficacy of proton pump inhibitors remains limited. Moreover, new biologicals have been identified which showed promising results in phase 2 trials and are now being studied in phase 3. This article aims to summarize and discuss recent advances and perspectives in the treatment of EoE.
引用
收藏
页码:339 / 348
页数:10
相关论文
共 55 条
[1]   Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis: Predictors of Nonresponse [J].
Alexander, Ryan ;
Alexander, Jeffrey A. ;
Akambase, Joseph ;
Harmsen, William Scott ;
Geno, Debra ;
Tholen, Crystal ;
Katzka, David A. ;
Ravi, Karthik .
DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (09) :3096-3104
[2]   Measurement of Observed Eating Behaviors in Patients With Active and Inactive Eosinophilic Esophagitis [J].
Alexander, Ryan ;
Alexander, Jeffrey A. ;
Ravi, Karthik ;
Geno, Debra ;
Tholen, Crystal ;
Mara, Kristin ;
Katzka, David A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (11) :2371-2373
[3]   Efficacy of Dietary Interventions for Inducing Histologic Remission in Patients With Eosinophilic Esophagitis: A Systematic Review and Meta-analysis [J].
Arias, Angel ;
Gonzalez-Cervera, Jesus ;
Tenias, Jose M. ;
Lucendo, Alfredo J. .
GASTROENTEROLOGY, 2014, 146 (07) :1639-1648
[4]   Acid suppressing therapy as a risk factor for Candida esophagitis [J].
Daniell, H. W. .
DISEASES OF THE ESOPHAGUS, 2016, 29 (05) :479-483
[5]  
De Heer J., 2020, DIGESTION, P1
[6]   Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review [J].
de Rooij, Willemijn E. ;
Dellon, Evan S. ;
Parker, Claire E. ;
Feagan, Brian G. ;
Jairath, Vipul ;
Ma, Christopher ;
Bredenoord, Albert J. .
DRUGS, 2019, 79 (13) :1419-1434
[7]  
Dellon ES., 2020, CLIN GASTROENTEROL H
[8]   A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis [J].
Dellon, Evan S. ;
Gupta, Sandeep K. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (11) :2149-2160
[9]   Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis [J].
Dellon, Evan S. ;
Katzka, David A. ;
Collins, Margaret H. ;
Gupta, Sandeep K. ;
Lan, Lan ;
Williams, James ;
Hirano, Ikuo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) :666-+
[10]   Epidemiology and Natural History of Eosinophilic Esophagitis [J].
Dellon, Evan S. ;
Hirano, Ikuo .
GASTROENTEROLOGY, 2018, 154 (02) :319-+